SCHEMBL29248809

SCHEMBL29248809

NC(=O)OS(=O)(=O)NCc1ccc(-c2ccnc3[nH]c(=O)ccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ENPP1 P22413 4/20 0.43
▸ ENPP3 O14638 1/20 0.43
▸ CHUK O15111 14/20 0.41
▸ IKBKB O14920 11/20 0.41
▸ ROCK1 Q13464 3/20 0.41
▸ INSR P06213 3/20 0.40
▸ MAPK8 P45983 3/20 0.40
▸ CAMKK2 Q96RR4 3/20 0.40
▸ NEK1 Q96PY6 2/20 0.38
▸ CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29248817 0.88 NUDT1 (0.41) ENPP1ENPP3CHUKIKBKBROCK1
SCHEMBL29248812 0.84 ENPP1 (0.42) ENPP1CHUKIKBKBROCK1INSR
SCHEMBL29691620 0.83 ENPP1 (0.56) ENPP1ENPP3CHUKIKBKBROCK1
SCHEMBL24600558 0.83 ENPP1 (0.56) ENPP1ENPP3CHUKIKBKBROCK1
SCHEMBL26679935 0.81 IKBKB (0.46) ENPP1ENPP3CHUKIKBKBROCK1
SCHEMBL29248776 0.80 CHUK (0.43) CHUKIKBKBROCK1INSRMAPK8
SCHEMBL29248792 0.80 ENPP1 (0.44) ENPP1ENPP3CHUKIKBKBROCK1
SCHEMBL29691621 0.79 CA12 (0.53) ENPP1ENPP3CHUKIKBKBROCK1
SCHEMBL24600502 0.79 CA12 (0.53) ENPP1ENPP3CHUKIKBKBROCK1
SCHEMBL24600501 0.78 CCNK (0.46) ENPP1ENPP3CHUKIKBKBROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116669726-A Novel naphthyridinone derivatives having inhibitory activity against exonuclease-phosphodiesterase and use thereof 谛希诺生物科技有限公司 2023-08-29 — — CN claimed
CN-116669726-A Novel naphthyridinone derivatives having inhibitory activity against exonuclease-phosphodiesterase and use thereof 谛希诺生物科技有限公司 2023-08-29 — — CN disclosed
Send feedback